These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Antithrombin III activity in relation to multiple administration of various doses of heparin to normal animals]. Kudriashov BA; Pastorova VE; Liapina LA Vopr Med Khim; 1985; 31(3):37-41. PubMed ID: 4024529 [TBL] [Abstract][Full Text] [Related]
5. Rethrombosis--warfarin or low-dose heparin? Wessler S; Gitel SN N Engl J Med; 1979 Oct; 301(16):889-91. PubMed ID: 384252 [No Abstract] [Full Text] [Related]
6. Development of heparin fractions: some overlooked considerations. Fareed J Semin Thromb Hemost; 1985 Apr; 11(2):227-36. PubMed ID: 3898374 [No Abstract] [Full Text] [Related]
8. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog. Hellebrekers LJ; Slappendel RJ; van den Brom WE Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027 [TBL] [Abstract][Full Text] [Related]
9. The effect of operation and subcutaneous heparin on plasma levels of antithrombin-III. Harbourne T; Nicolaides AN Thromb Res; 1986 Sep; 43(6):657-62. PubMed ID: 3764810 [TBL] [Abstract][Full Text] [Related]
10. Heparin-antithrombin III binding. In vitro and in vivo studies. Chan V; Chan TK Haemostasis; 1979; 8(6):373-89. PubMed ID: 511016 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of thrombophlebitis of the extremities by paravasal and intraspongiosa infusions of a thrombolytic mixture]. Askerkhanov RP; Zakariev ZM Vestn Khir Im I I Grek; 1982 Oct; 129(10):55-9. PubMed ID: 7179665 [No Abstract] [Full Text] [Related]
12. Results of low-dose heparin prophylaxis of venous thrombosis considering plasma heparin and anti-thrombin III concentration. Tilsner V; Müller U; Reuter H; Raedler A Thromb Res; 1980 Feb 1-15; 17(3-4):519-25. PubMed ID: 7368173 [No Abstract] [Full Text] [Related]
13. Antithrombin III in patients with acute deep vein thrombosis during heparin treatment (subcutaneous and intravenous) and during and after treatment with oral coumarins. Andersson G; Fagrell B; Holmgren K; Johnsson H; Ljungberg B; Wilhelmsson S Thromb Res; 1984 May; 34(4):333-40. PubMed ID: 6740566 [TBL] [Abstract][Full Text] [Related]
15. The use of an automated analyzer in the evaluation of antithrombin III and heparin. Scully MF Semin Thromb Hemost; 1983 Oct; 9(4):309-20. PubMed ID: 6658462 [No Abstract] [Full Text] [Related]
16. Value of streptokinase and heparin in treatment of acute deep venous thrombosis. A coded investigation. Robertson BR; Nilsson IM; Nylander G Acta Chir Scand; 1968; 134(3):203-8. PubMed ID: 4893315 [No Abstract] [Full Text] [Related]
17. Protection against venous thrombosis in an antithrombin-III deficient patient suffering from episodes of arterial thrombosis requiring major surgery. Effects of oral stanozolol in combination with subcutaneous heparin and intravenous AT-III. Jespersen J; Gram J; Kluft C; Astrup T Am J Clin Pathol; 1985 Jun; 83(6):768-71. PubMed ID: 4003344 [TBL] [Abstract][Full Text] [Related]
18. Problems of deep venous thrombosis during pregnancy. Pfeifer GW; von Nathusius U Acta Univ Carol Med Monogr; 1972; 52():193-4. PubMed ID: 4669822 [No Abstract] [Full Text] [Related]
19. Continuous heparin infusion requirements. Diagnostic and therapeutic implications. White TM; Bernene JL; Marino AM JAMA; 1979 Jun; 241(25):2717-20. PubMed ID: 448818 [No Abstract] [Full Text] [Related]
20. Current concepts: the use of heparin. Deykin D N Engl J Med; 1969 Apr; 280(17):937-8. PubMed ID: 5775632 [No Abstract] [Full Text] [Related] [Next] [New Search]